Sarepta Therapeutics, Inc. (SRPT)
16.73
+0.33
(+2.01%)
USD |
NASDAQ |
Mar 16, 14:57
Sarepta Therapeutics Profit Margin (Quarterly) : -93.07% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 18.15% |
| REGENXBIO, Inc. | -221.3% |
| Keros Therapeutics, Inc. | -6.09K% |
| Gilead Sciences, Inc. | 27.44% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.94% |
| Return on Assets | -23.47% |
| Return on Invested Capital | -32.87% |
| Gross Profit Margin (Quarterly) | 7.70% |
| Operating Margin (Quarterly) | -92.58% |
| Return on Net Operating Assets | -40.18% |